OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program
David W. Dodick, Catherine C. Turkel, Ronald E. DeGryse, et al.·2010·Headache The Journal of Head and Face Pain